Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Glypican 3 as a Predictive Marker in Colorectal Cancer Patients

NCT04728139 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04728139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Glypican 3 as a Predictive Marker in Colorectal Cancer Patients
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2022
Completion date
October 31, 2024
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer